Bonnie L. Bassler - 30 Jun 2026 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Reporting relationship: Director
Issuer ticker: RPRX
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Jun 2026, 17:15:17 UTC
Prior SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Sean Weisberg, as Attorney-in-Fact for Bonnie L. Bassler

Key filing fact

Bonnie L. Bassler filed Form 4 for Royalty Pharma plc (RPRX) on 30 Jun 2026.

Key facts

This page summarizes Bonnie L. Bassler's Form 4 filing for Royalty Pharma plc (RPRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Jun 2026, 17:15.

Change

Previous filing in this sequence was filed on 08 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001683607 Primary reporting owner

Bassler Bonnie L

Relationship: Director
Address: C/O ROYALTY PHARMA PLC, 110 E. 59TH STREET, NEW YORK
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for Bonnie L. Bassler
Signature date: 30 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPRX transaction

Class A Ordinary Shares

Award

Transaction value
Shares: +689
Change %: +0.88%
Price: $54.40^*
Shares after: 79,181
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.